News | News By Subject | News by Disease News By Date | Search News

Insomnia News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Sends Sciecure Pharma Scathing Letter Over Insomnia Drug Sales Ad     11/10/2014
Merck & Co. (MRK) Wins FDA Approval For New Type Of Sleeping Pill     8/15/2014
FDA Slashes Starting Dose For Sunovion Pharmaceuticals Inc.'s Lunesta; Warns Risk Of Next-Day Impairment     5/16/2014
FDA Approves Vanda Pharmaceuticals, Inc. (VNDA)'s Sleep Disorder Drug HETLIOZ™     2/3/2014
Vanda Pharmaceuticals, Inc. (VNDA)'s Experimental Drug Helps The Blind Sleep, FDA Staff Says; Stock Soars +95.93% At Market Close (November 12, 2013)     11/12/2013
FDA Rejects Merck & Co., Inc. (MRK)'s Insomnia Drug     7/2/2013
FDA Panel Backs Merck & Co., Inc. (MRK) Insomnia Drug Suvorexant, But at Lower Doses     5/23/2013
FDA Staff Says Merck & Co., Inc. (MRK)'s Sleep Drug Effective, Questions Dosage     5/21/2013
Promising Insomnia Pill From Merck & Co., Inc. (MRK) Remains "Critical" to Future Amid Recent Setbacks     2/12/2013
Vanda Pharmaceuticals, Inc. (VNDA) Sleep Drug Effective in Second Late-Stage Trial     1/23/2013
Merck & Co., Inc. (MRK)'s Recipe for Zzzzs in FDA's Hands Now     11/9/2012
Merck & Co., Inc. (MRK) Aims to Make Billions Off a Safer Ambien     11/2/2012

News from Around the Web
Ebb Insomnia Therapy System Cools Front Of Head To Help Stop Racing Thoughts, Ebb Therapeutics Reveals     6/14/2017
How Bad Is Weekend 'Social Jet Lag' For Your Heart? Sleep Reveals     6/8/2017
Sleep Deprivation May Cause Brain To Eat Itself, Marche Polytechnic University Study Reveals     5/30/2017
Why Women Are More Likely To Experience Sleep Problems Than Men, McGill University Study     9/14/2016
Both Insomnia Or Oversleeping Might Up Your Stroke Risk, University Hospital Essen Study     8/4/2016
This App Is Conquering Insomnia And Depression At The Same Time, Big Health Reveals     7/28/2016
Tired Of Being Tired? Take Control Of Your Sleep With Sleepman, Avantechs Reveals     6/21/2016
New Implantable Device Eases Sleep Apnea, University of Alabama at Birmingham Reveals     6/7/2016
New Implantable Device Eases Sleep Apnea, University of Alabama at Birmingham Reveals     6/6/2016
Antidepressants: Rise In Off-Label Prescriptions, McGill University Study     5/26/2016
First Ever Clinical Study Using Brainwave Optimization Technology To Treat Insomnia, Wake Forest University Baptist Medical Center Reveals     5/26/2016
Insomnia Linked To Loose Connections In The Brain, Guangdong No. 2 Provincial People's Hospital Study     4/5/2016
10 Tips For A Good Night's Sleep     3/21/2016
Are These New Therapeutic Devices A Medical Miracle Or The Emperor’s New Cloak?     3/9/2016
No Link Found Between Insomnia And Cholesterol Levels, St. Michael's Hospital Study Reveals     3/3/2016

Press Releases
University of Warwick Release: Children's Sleep Quality Linked To Mothers' Insomnia     8/31/2017
Blake Insomnia Therapeutics (BKIT) Announces Submitting Clinical Trial Application For Phase II Clinical Testing     8/25/2017
Neurotech Company Rythm Launches Dreem, A Completely New Category Of Product That Enhances Sleep     6/15/2017
Minerva Neurosciences (NERV) Announces Amended Agreement For MIN-202 In Insomnia     6/1/2017
Eisai Company (ESALY.PK) Release: Transfer Of Rights To Insomia Treatment / Anaesthesia Induction Agent Flunitrazepam In Japan     1/16/2017
Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin ("PedPRM") To Be Marketed By Kuhnil Pharmaceutical Company In South Korea     12/6/2016
Radiological Society of North America (RSNA) Release: Short-term Sleep Deprivation Affects Heart Function     12/2/2016
Neurim Pharmaceuticals Grants Aspen Pharmacare Australia Marketing Rights For Paediatric Prolonged-Release Melatonin ("PedPRM") In Australia And New Zealand     11/16/2016
ErgoMed Completes Recruitment Of Phase lla Clinical Trial Of Lorediplon In Insomnia In Collaboration With Co-Development Partner Ferrer     9/8/2016
Vanda Pharmaceuticals, Inc. (VNDA) Release: HETLIOZ Is Now Available For The Treatment Of Non-24-Hour Sleep-Wake Disorder In Germany     8/1/2016
Pernix (PTX) Announces Positive Phase IV Results Of Silenor Vs. Zolpidem Head-To-Head Arousability Study     6/16/2016
Lupin (LUPN.BO) Launches Generic Intermezzo Sublingual Tablets In The US     4/6/2016
American Academy of Neurology Release: Can't Sleep? Street Lights May Be Keeping You Awake     3/2/2016
New Pilot Study Finds The Fisher Wallace Laboratories Stimulator Effective In Treating Bipolar Depression     10/9/2015
Minerva Neurosciences, Inc. (NERV) Provides Update On Clinical Development Program With MIN-202, Selective Orexin-2 Receptor Antagonist     9/24/2015